Homage to gender, green light for puberty-blocking drug
In the Official Journal the news that triptorelin will be paid for entirely by the National Health Service «in selected cases in which puberty is incongruent with gender identity». Yet another homage to the LGBT ideology, which does not take health risks into account and will contribute to ignoring the moral data even more, endorsing any perception of the minor.
Triptorelin is a drug that, among the various uses, It is used to delay pubertal development in boys between the ages 12 and i 16 years. In Italy, already since 2013, the Careggi hospital in Florence uses it for those so-called cases of gender dysphoria affecting minors. In essence, the pubertal development of the child who says he does not recognize himself in his biological sex or who has some doubts about his sexual psychological identity is blocked and he is parked in a sexual limbo so that, some time has passed, clarify your ideas and decide which sex you "belong to" or proceed with surgical "sexual rectification" on the assumption that it is easier, as his sexual attributes have not yet fully developed. Read More